Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study-Reference-Cited by-同舟云学术

Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study

Published:2021-01-19 Issue:5 Volume:105 Page:e52-e53
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Boyarsky Brian J.,Ou Michael T.,Werbel William A.,Avery Robin K.,Clarke William A.,Tobian Aaron A.R.,Massie Allan B.,Segev Dorry L.,Garonzik Wang Jacqueline M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference4 articles.

1. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.;Klein;J Clin Invest,2020

2. Convalescent plasma to treat COVID-19: possibilities and challenges.;Roback;JAMA,2020

3. Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in Nashville, Tennessee.;Patel;JAMA,2020

4. SARS-CoV-2 viral dynamics in immunocompromised patients.;Caillard;Am J Transplant,2021

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral presence and immunopathology in a kidney transplant recipient with fatal COVID-19: a clinical autopsy report;Journal of Leukocyte Biology;2024-01-22

2. Active and Passive Immunization Approaches in Transplant Recipients;Current Transplantation Reports;2023-08-22

3. Monoclonal antibodies and oral pills for COVID-19: new possibilities for solid organ transplanted patients?;Chirurgia;2022-11

4. Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study;European Respiratory Journal;2022-10-20

5. COVID-19 in Recent Lung Transplant Recipients: Clinical Outcomes and Management Strategies;Transplantation Proceedings;2022-07